For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

The study showed diabetic patients taking GLP-1 drugs, such as semaglutide and tirzepatide, faced significantly lower risks of 30-day readmission, wound re-opening and hematoma after surgery, compared ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...